Publikation

Distinct mechanisms of hypoglycaemia in patients with somatostatin-secreting neuroendocrine tumours

Wissenschaftlicher Artikel/Review - 27.06.2019

Bereiche
PubMed
DOI

Zitation
Wiesli P, Pavlicek V, Brändle M, Pfammatter T, Perren A, Schmid C. Distinct mechanisms of hypoglycaemia in patients with somatostatin-secreting neuroendocrine tumours. Endocrinol Diabetes Metab 2019; 2:e00083.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Endocrinol Diabetes Metab 2019; 2
Veröffentlichungsdatum
27.06.2019
eISSN (Online)
2398-9238
Seiten
e00083
Kurzbeschreibung/Zielsetzung

Introduction
Somatostatin-secreting neuroendocrine tumours may present with diabetes, cholelithiasis and steatorrhoea. In addition, hypoglycaemia has been associated with somatostatinomas. However, the mechanism of hypoglycaemia in patients with somatostatinomas has not been well characterized.

Methods
We describe two patients with recurrent neuroglycopenic episodes caused by somatostatin-secreting neuroendocrine tumours in the liver, detected by abdominal CTs and whole-body octreotide scintigraphy scans and confirmed by biopsy.

Results
Pancreatic islet hyperplasia and co-secretion of insulin (in addition to somatostatin) from tumour cells, respectively, have been characterized as completely distinct mechanisms of hypoglycaemia at both the functional and morphological levels in these two patients.

Conclusions
Hypoglycaemia may be caused by different mechanisms in patients with somatostatinomas.